Screening of Niemann-Pick Disease, Type C in a Psychiatric Population
Condition:   Psychiatric Adults PatientsInterventions:   Biological: Blood sampling;   Biological: BiopsySponsor:   University Hospital, GrenobleRecruiting - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 11, 2016 Category: Research Source Type: clinical trials

Screening of Niemann-Pick Disease, Type C in a Psychiatric Population
Condition:   Psychiatric Adults Patients Interventions:   Biological: Blood sampling;   Biological: Biopsy Sponsor:   University Hospital, Grenoble Recruiting - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 11, 2016 Category: Research Source Type: clinical trials

Study of 2-hydroxypropyl-β-cyclodextrin (HP-β-CD) to Treat Niemann-Pick Type C1 (NPC1) Disease
Condition:   Niemann-Pick Disease, Type CInterventions:   Drug: HP-β-CD;   Drug: Sham Procedure ControlSponsor:   Vtesse Inc.Not yet recruiting - verified August 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 18, 2015 Category: Research Source Type: clinical trials